The Case for Adolescent HIV Vaccination in South Africa: A Cost-Effectiveness Analysis

Despite comprising 0.7% of the world population, South Africa is home to 18% of the global human immunodeficiency virus (HIV) prevalence. Unyielding HIV subepidemics among adolescents threaten national attempts to curtail the disease burden. Should an HIV vaccine become available, establishing its p...

Descripción completa

Detalles Bibliográficos
Autores principales: Moodley, Nishila, Gray, Glenda, Bertram, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291560/
https://www.ncbi.nlm.nih.gov/pubmed/26825890
http://dx.doi.org/10.1097/MD.0000000000002528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291560/
https://www.ncbi.nlm.nih.gov/pubmed/26825890
http://dx.doi.org/10.1097/MD.0000000000002528

Ejemplares similares